Latest News
December 6, 2021
Merck Canada Announces Expansion of Manufacturing for Molnupiravir, an Investigational Oral Antiviral Medicine for the Treatment of COVID-19
November 26, 2021
Kingston Health Sciences Centre Expands Lung Diagnostic Assessment Program to Napanee, ON
November 8, 2021
Merck Canada and Guy Lafleur Team Up Against Lung Cancer
September 13, 2021
Marwan Akar Appointed as President & Managing Director of Merck Canada
April 28, 2021
Merck Canada and MaRS Announce Winners of the Lung Cancer Innovation Challenge
This website is designed to provide members of the media with quick and easy access to recent information about Merck. For additional information, please visit 'About Merck'.
For journalists with a media inquiry, please contact us: 1-833-90MERCK (1-833-906-3725).